Glutathione and glutamate in schizophrenia: a 7T MRS study.
Ontology highlight
ABSTRACT: In schizophrenia, abnormal neural metabolite concentrations may arise from cortical damage following neuroinflammatory processes implicated in acute episodes. Inflammation is associated with increased glutamate, whereas the antioxidant glutathione may protect against inflammation-induced oxidative stress. We hypothesized that patients with stable schizophrenia would exhibit a reduction in glutathione, glutamate, and/or glutamine in the cerebral cortex, consistent with a post-inflammatory response, and that this reduction would be most marked in patients with "residual schizophrenia", in whom an early stage with positive psychotic symptoms has progressed to a late stage characterized by long-term negative symptoms and impairments. We recruited 28 patients with stable schizophrenia and 45 he
SUBMITTER: Kumar J
PROVIDER: S-EPMC7156342 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA